Hepatitis C virus vaccines among people who inject drugs

Research output: Contribution to journalArticlepeer-review

Abstract

Most people who inject drugs (PWID) are infected with hepatitis C virus (HCV), and PWID have the highest risk of HCV infection of any risk group. The incidence of HCV infection is 5%-25% per year, demonstrating continued need for HCV infection prevention in PWID. Existing data in chimpanzees and PWID suggest that protective immunity against persistent HCV infection is achievable. Due to the high incidence of infection, PWID are both the most likely to benefit from a vaccine and a population in which vaccine efficacy could be tested. Challenges to testing a vaccine in PWID are significant. However, the first HCV vaccine trial in at-risk HCV-uninfected PWID was initiated in 2012. The results will likely guide future vaccine development and strategies for vaccination of this and other high-risk populations.

Original languageEnglish (US)
Pages (from-to)S46-S50
JournalClinical Infectious Diseases
Volume57
Issue numberSUPPL.2
DOIs
StatePublished - 2013

Keywords

  • Hepatitis
  • Hepatitis C virus
  • Injection drug users
  • Vaccine
  • Viral hepatitis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Hepatitis C virus vaccines among people who inject drugs'. Together they form a unique fingerprint.

Cite this